article thumbnail

Low diffusing capacity for carbon monoxide in chronic thromboembolic pulmonary hypertension: a biomarker for microvascular disease?

Heart BMJ

Major vessel disease is subject to mechanical treatments such as surgical pulmonary endarterectomy (PEA) and balloon pulmonary angioplasty (BPA). Fibrotic obstructions resulting from unresolved pulmonary emboli constitute the major vessel disease component.

article thumbnail

Abstract 4136687: VTRNA2-1 Promoter Methylation as a Prognostic Biomarker in Peripheral Artery Disease: Implications for Maternal Nutritional Influence

Circulation

Inclusion criteria included adults over 20 years old, consent to participate, and a requirement for angioplasty. These findings suggest that VTRNA2-1 promoter methylation status could serve as a valuable biomarker for predicting prognosis and guiding treatment strategies in PAD. 6.97, p=0.024), amputations (HR 2.58, 95% CI 1.02-6.57,

article thumbnail

Abstract 056: Patterns of Care in the Management of Intracranial Atherosclerosis?related Large Vessel Occlusion–the RESCUE?LVO survey

Stroke: Vascular and Interventional Neurology

Treatment of ICAS‐LVO with rescue stenting and/or angioplasty has shown promising outcomes, but diagnosing ICAS‐LVO during MT can be challenging [2, 3]. Most respondents (86%) preferred acute treatment of ICAS‐LVO with rescue stenting (RS) +/‐ angioplasty.

article thumbnail

Patterns of Care in the Diagnosis and Management of Intracranial Atherosclerosis?Related Large?Vessel Occlusion: The Rescue?LVO Survey

Stroke: Vascular and Interventional Neurology

Most respondents (86%) preferred acute treatment of ICAS‐LVO with rescue stenting (RS)±angioplasty. Fear of hemorrhagic complications (74%) was the most compelling reason not to perform RS±angioplasty. However, in patients who achieved recanalization with a severe fixed focal stenosis, most (58%) recommended primary medical management.

article thumbnail

Is OMI an ECG Diagnosis?

Dr. Smith's ECG Blog

1] European guidelines add "regardless of biomarkers". Refractory ischemic chest pain continued and trop increased to 160,000ng/L, with subtle convex anterior ST elevation: The patient was brought back to cath lab for stenting of LAD and balloon angioplasty to OM. But only 6.4%

STEMI 121
article thumbnail

A Tough ECG, But Learn From It!

Dr. Smith's ECG Blog

These patients have worse outcomes: higher mortality, more CHF, higher biomarkers, and worse ejection fractions than the NonSTEMI patients with open arteries. Studies show that 30% of NonSTEMI have an occluded infarct artery at the time of angiography done 24 hours after presentation. This is because of subtle ECG findings.

STEMI 52
article thumbnail

Rise of the Lysenkoist Cardiologists

Dr. Anish Koka

The presentation for this condition is usually not subtle and presents with severe chest pain, electrocardiographic changes, and elevated cardiac biomarkers evident on blood tests. Women also had more cardiovascular risk factors, including hypertension (66.6% versus 63.2%; P <0.001), hyperlipidemia (68.9% years of age versus 59.0±8.4